Compare EBS & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBS | ARL |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 303.3M | 350.0M |
| IPO Year | 2006 | 1999 |
| Metric | EBS | ARL |
|---|---|---|
| Price | $5.10 | $20.51 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 946.0K | 2.4K |
| Earning Date | 11-02-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $742,900,000.00 | $50,014,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.36 | $12.42 |
| 52 Week High | $14.06 | $24.44 |
| Indicator | EBS | ARL |
|---|---|---|
| Relative Strength Index (RSI) | 27.56 | 45.07 |
| Support Level | $4.36 | $14.52 |
| Resistance Level | $7.18 | $19.25 |
| Average True Range (ATR) | 0.42 | 0.65 |
| MACD | -0.10 | -0.34 |
| Stochastic Oscillator | 3.79 | 4.41 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments: the acquisition, development, ownership and management of multifamily properties (Residential Segment) and the acquisition, ownership and management of commercial real estate properties (Commercial Segment). Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.